{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:38:05Z","timestamp":1780087085356,"version":"3.54.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1097\/md.0000000000006848","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T13:25:21Z","timestamp":1494422721000},"page":"e6848","source":"Crossref","is-referenced-by-count":40,"title":["Prognostic impact of C-reactive protein\/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy"],"prefix":"10.1097","volume":"96","author":[{"given":"Young W.","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-41-20210226","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-41-20210226","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4143\/crt.2017.130","article-title":"Prediction of cancer incidence and mortality in Korea, 2017","volume":"49","author":"Jung","year":"2017","journal-title":"Cancer Res Treat"},{"key":"R3-41-20210226","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2004.10.014","article-title":"Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes","volume":"47","author":"Le Chevalier","year":"2005","journal-title":"Lung Cancer"},{"key":"R4-41-20210226","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"R5-41-20210226","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jtho.2015.10.008","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer","volume":"11","author":"Nicholson","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R6-41-20210226","first-page":"2993","article-title":"Prognostic value of the standardized uptake value maximum change calculated by dual-time-point (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with advanced non-small-cell lung cancer","volume":"9","author":"Jin","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R7-41-20210226","doi-asserted-by":"crossref","first-page":"26916","DOI":"10.18632\/oncotarget.8309","article-title":"Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy","volume":"7","author":"Berardi","year":"2016","journal-title":"Oncotarget"},{"key":"R8-41-20210226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2015.11.020","article-title":"Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy","volume":"55","author":"Tokito","year":"2016","journal-title":"Eur J Cancer"},{"key":"R9-41-20210226","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s13277-015-3776-5","article-title":"Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes","volume":"37","author":"Lee","year":"2016","journal-title":"Tumour Biol"},{"key":"R10-41-20210226","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"key":"R11-41-20210226","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ijrobp.2015.02.018","article-title":"Pretreatment modified Glasgow prognostic score predicts clinical outcomes after stereotactic body radiation therapy for early-stage non-small cell lung cancer","volume":"92","author":"Kishi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-41-20210226","doi-asserted-by":"crossref","first-page":"e395","DOI":"10.5301\/jbm.5000222","article-title":"Neutrophil-lymphocyte ratio as a prognostic marker for chemotherapy in advanced lung cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Int J Biol Markers"},{"key":"R13-41-20210226","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/107327481602300312","article-title":"Platelet-to-lymphocyte ratio and use of NSAIDs during the perioperative period as prognostic indicators in patients with NSCLC undergoing surgery","volume":"23","author":"Lee","year":"2016","journal-title":"Cancer Control"},{"key":"R14-41-20210226","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.bjc.6605603","article-title":"Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer","volume":"102","author":"Gagnon","year":"2010","journal-title":"Br J Cancer"},{"key":"R15-41-20210226","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2407-10-50","article-title":"Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study","volume":"10","author":"Arrieta","year":"2010","journal-title":"BMC Cancer"},{"key":"R16-41-20210226","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/JTO.0b013e31819578c8","article-title":"Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy","volume":"4","author":"Koch","year":"2009","journal-title":"J Thorac Oncol"},{"key":"R17-41-20210226","first-page":"665","article-title":"Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer","volume":"31","author":"Wilop","year":"2008","journal-title":"Onkologie"},{"key":"R18-41-20210226","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11912-002-0023-1","article-title":"The role of C-reactive protein as a prognostic indicator in advanced cancer","volume":"4","author":"Mahmoud","year":"2002","journal-title":"Curr Oncol Rep"},{"key":"R19-41-20210226","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1245\/s10434-016-5579-3","article-title":"Prognostic Value of the CRP\/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer","volume":"24","author":"Liu","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R20-41-20210226","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.7150\/jca.15401","article-title":"Exploration and validation of C-reactive protein\/albumin ratio as a novel inflammation-based prognostic marker in nasopharyngeal carcinoma","volume":"7","author":"Zhang","year":"2016","journal-title":"J Cancer"},{"key":"R21-41-20210226","first-page":"995","article-title":"Prognostic significance of the preoperative ratio of C-reactive protein to albumin in patients with colorectal cancer","volume":"36","author":"Shibutani","year":"2016","journal-title":"Anticancer Res"},{"key":"R22-41-20210226","doi-asserted-by":"crossref","first-page":"e0138657","DOI":"10.1371\/journal.pone.0138657","article-title":"A novel inflammation-based prognostic score, the C-reactive protein\/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma","volume":"10","author":"Xu","year":"2015","journal-title":"PLoS One"},{"key":"R23-41-20210226","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.18632\/oncotarget.13053","article-title":"The C-reactive protein\/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"R25-41-20210226","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.1038\/srep10481","article-title":"Ratio of C-reactive protein\/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci Rep"},{"key":"R26-41-20210226","doi-asserted-by":"crossref","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"},{"key":"R27-41-20210226","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"R28-41-20210226","first-page":"471","article-title":"C-reactive protein and malignancy: clinico-pathological association and therapeutic implication","volume":"32","author":"Wang","year":"2009","journal-title":"Chang Gung Med J"},{"key":"R29-41-20210226","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.cca.2012.05.009","article-title":"Interleukin 6 and C-reactive protein in esophageal cancer","volume":"413","author":"Groblewska","year":"2012","journal-title":"Clin Chim Acta"},{"key":"R30-41-20210226","first-page":"157","article-title":"Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative\/supportive care","volume":"5","author":"MacDonald","year":"2007","journal-title":"J Support Oncol"},{"key":"R31-41-20210226","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1172\/JCI32533","article-title":"IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland","volume":"117","author":"Sansone","year":"2007","journal-title":"J Clin Invest"},{"key":"R32-41-20210226","doi-asserted-by":"crossref","first-page":"djv020","DOI":"10.1093\/jnci\/djv020","article-title":"Effect of cellular senescence on the growth of HER2-positive breast cancers","volume":"107","author":"Zacarias-Fluck","year":"2015","journal-title":"J Nat Cancer Inst"},{"key":"R33-41-20210226","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"key":"R34-41-20210226","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1046\/j.1440-1746.2002.02873.x","article-title":"Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma","volume":"17","author":"Huang","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R35-41-20210226","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1097\/01.mcg.0000155514.17715.39","article-title":"Inhibition of albumin synthesis in chronic diseases: molecular mechanisms","volume":"39","author":"Chojkier","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R36-41-20210226","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1001\/archinte.165.18.2063","article-title":"High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey","volume":"165","author":"Miller","year":"2005","journal-title":"Arch Intern Med"},{"key":"R37-41-20210226","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA"},{"key":"R38-41-20210226","first-page":"205","article-title":"Differences in inflammatory markers in a non-smoking and smoking Mexican population","volume":"61","author":"Perez-Bautista","year":"2009","journal-title":"Rev Invest Clin"},{"key":"R39-41-20210226","first-page":"517","article-title":"Initial analysis of relationship between plasma platinum concentration and hematological adverse reaction associated with weekly chemotherapy using nedaplatin in combination with radiotherapy for cervical carcinoma","volume":"31","author":"Hamada","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"R40-41-20210226","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.hoc.2016.08.001","article-title":"First-line systemic therapy for non-small cell lung cancer","volume":"31","author":"Heist","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"key":"R41-41-20210226","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1200\/JCO.2007.14.8494","article-title":"First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations","volume":"26","author":"Sequist","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:49:22Z","timestamp":1620960562000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201705120-00041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":40,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006848","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}